BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34046453)

  • 1. Critical prognostic value of the log odds of negative lymph nodes/tumor size in rectal cancer patients.
    Xie JB; Pang YS; Li X; Wu XT
    World J Clin Cases; 2021 May; 9(15):3531-3545. PubMed ID: 34046453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection.
    Wei Z; Mao R; Zhang Y; Bi X; Zhou J; Li Z; Huang Z; Chen X; Zhao J; Zhao H; Cai J
    Ann Transl Med; 2021 Feb; 9(3):250. PubMed ID: 33708877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
    Huang X; Hu P; Yan F; Zhang J
    Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
    Jiang S; Zhao L; Xie C; Su H; Yan Y
    Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
    [No Abstract]   [Full Text] [Related]  

  • 6. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.
    Huang B; Chen C; Ni M; Mo S; Cai G; Cai S
    Int J Surg; 2016 Aug; 32():24-30. PubMed ID: 27321382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy.
    Li X; Lu H; Xu K; Wang H; Liang X; Hu Z
    BMC Cancer; 2017 Mar; 17(1):227. PubMed ID: 28351352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
    Chen T; Zhan X; Chen X; Jiang M; Wan H; Fu B; Chen L
    Front Oncol; 2022; 12():895413. PubMed ID: 35928878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer.
    Li Q; Zhuo C; Liang L; Zheng H; Li D; Cai S
    Medicine (Baltimore); 2015 Jan; 94(3):e395. PubMed ID: 25621683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size and number of lymph nodes were risk factors of recurrence in stage II colorectal cancer.
    Tong S; Li M; Bao Y; Zhang L; Lu P; Tong T; Peng J
    BMC Cancer; 2023 Jun; 23(1):518. PubMed ID: 37280520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.
    Wu SG; Sun JY; Zhou J; Li FY; Zhou H; Lin Q; Lin HX; Bao Y; He ZY
    Radiat Oncol; 2014 Dec; 9():284. PubMed ID: 25511525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LODDS is superior to lymph node ratio for the prognosis of node-positive rectal cancer patients treated with preoperative radiotherapy.
    Huang B; Ni M; Chen C; Cai G; Cai S
    Tumori; 2017 Jan; 103(1):87-92. PubMed ID: 27716883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of negative lymph nodes should be considered for incorporation into staging for breast cancer.
    Wu SG; Wang Y; Zhou J; Sun JY; Li FY; Lin HX; He ZY
    Am J Cancer Res; 2015; 5(2):844-53. PubMed ID: 25973321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage.
    Wang F; Gao SG; Xue Q; Tan FW; Gao YS; Mao YS; Wang DL; Zhao J; Li Y; Yu XY; Cheng H; Zhao CG; Mu JW
    World J Clin Cases; 2021 Jan; 9(1):24-35. PubMed ID: 33511169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease.
    Quan Q; Zhu M; Liu S; Chen P; He W; Huang Y; Rong Y; Qiu H; Zhang B; Xia L
    J Cancer; 2019; 10(4):1052-1059. PubMed ID: 30854111
    [No Abstract]   [Full Text] [Related]  

  • 17. The Log Odds of Positive Lymph Nodes Stratifies and Predicts Survival of High-Risk Individuals Among Stage III Rectal Cancer Patients.
    Lee CW; Wilkinson KH; Sheka AC; Leverson GE; Kennedy GD
    Oncologist; 2016 Apr; 21(4):425-32. PubMed ID: 26975865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer.
    Wu SG; Zhang ZQ; Liu WM; He ZY; Li FY; Lin HX; Sun JY; Lin H; Li Q
    Oncotarget; 2016 Apr; 7(16):22497-507. PubMed ID: 26992210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
    Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
    Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population-based study.
    Liu Y; Yang H; Fu H; Li M; Feng Z; Peng Z; Liang Z; Wang H
    Thorac Cancer; 2019 Jul; 10(7):1636-1643. PubMed ID: 31237106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.